Full story via BioPharma Dive: #EliLilly #Orforglipron #GLP1 #ObesityTreatment #MetabolicDisease #BiopharmaInnovation #ClinicalTrials #FDA #DrugDevelopment #LifeSciences To view or add a comment, sign in FDA approves globally first obesity pill FDA approves Novo Nordisks first oral GLP-1 pill Wegovy for obesity, offering an injection-free option and improving long-term treatment adherence
Other interactions: Enhanced glucose-lowering effect: alcohol, anabolic steroids, MAOIs, testosterone
Primarily used in the treatment of hormone-sensitive cancers and certain gynecological conditions
Support the immune system: Glutamine is an energy source for the immune system and supports the gut, regulates immune responses, aids recovery from an illness, and protects against immune suppression
Plan your highest-protein meals for the days when your appetite is slightly more cooperative
12 Zhou, L., Qu, H., Yang, L., & Shou, L